REALEX PROPERTIES CORP.

Inactive Instrument

All News Realex Properties Corp.

Equities

RP

CA7560415050

End-of-day quote Toronto S.E. Other stock markets
- ^CAD	-

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Realex Properties : RepliCel Announces CEO Update	16-02-16	MW
Realex Properties : RepliCel Life Sciences Announces Participation in 23rd World Congress of Dermatology, Vancouver, BC	15-06-05	PR
Realex Properties : RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference	15-05-21	PR
Realex Properties : RepliCel Life Sciences Selected to Present at Cavendish Global Health Impact Forum	15-05-07	PR
Realex Properties : RepliCel Announces 2014 Fourth Quarter and Year-End Financial Results	15-04-29	PR
Realex Properties : RepliCel Life Sciences Receives Approval to Conduct Clinical Trial for Patients with Chronic Achilles Tendinosis	15-04-15	PR
Realex Properties : RepliCel Life Sciences Receives TSX Venture Exchange Approval to Extend Warrant Expiry Dates	15-04-07	PR
Realex Properties : RepliCel Life Sciences Applies to Extend Warrant Expiry Dates	15-04-02	PR
Realex Properties : RepliCel Life Sciences in Japan for Key Industry Meetings	15-03-12	PR
Realex Properties : RepliCel Life Sciences to Present at 11th Annual Phacilitate Cell & Gene Therapy Forum in Washington, DC	15-01-20	PR
Realex Properties : RepliCel Life Sciences to Present at Biotech Showcase 2015 in San Francisco	15-01-07	PR
Realex Properties : Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness	14-12-22	PR
Realex Properties : R. Lee Buckler: How RepliCel Is Harnessing the Awesome Power of Cell Therapy	14-11-10	MW
Realex Properties : RepliCel to Present Clinical Trial Update at Stem Cell Meeting on the Mesa Partnering Forum in California	14-10-02	MW
Realex Properties : RepliCel Retains Market-Making Services	14-09-12	MW
Realex Properties : RepliCel Life Sciences' Licensing Partner, Shiseido, Opens Cell Processing and Expansion Facility in Japan to Advance RCH-01, a Treatment for Pattern Baldness	14-05-20	MW
RepliCel to Present RCH-01 Phase 1 Clinical Data at the 13th Congress of the Japanese Society for Regenerative Medicine	14-02-27	MW

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
RP Stock
News Realex Properties Corp.

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer